Search Results 651-660 of 18296 for Hepatitis C

  1. Fidanacogene elaparvovec-dzkt (intravenous route) - Side effects & uses - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Cancer or; Liver disease (eg, hepatitis B or C, non-alcoholic fatty liver ...

  2. A Study to Evaluate the Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses - Mayo Clinic

    A Study to Evaluate the Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses.

  3. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    Subjects who are hepatitis C antibody positive will need to have a negative PCR result before enrollment. Those who are hepatitis C PCR positive will be ...

  4. Publications - Grace Lin, M.D., M.B.A. - Mayo Clinic

    Budgetary Effects of Policies That Would Increase Hepatitis C Treatment Congressional Budget Office. 2024. Naser JA, Alexandrino FB, Harada T, Michelena HI ...

  5. Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic develops regenerative medicine strategies for treating ...

  6. A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer - Mayo Clinic

    Positive Hepatitis C virus antibody: Hepatitis C virus RNA by PCR is necessary. Detectable Hepatitis C virus RNA suggests chronic hepatitis C. Known ...

  7. Overview - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic develops regenerative medicine strategies for treating ...

  8. Study of BIIB092 in Participants With Progressive Supranuclear Palsy - Mayo Clinic

    Any other sound medical, psychiatric, and/or social reason as determined by the Investigator. Current hepatitis C or hepatitis B infection. Current hepatitis C ...

  9. Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma - Mayo Clinic

    Patients with hepatitis C must have negative hepatitis C virus (HCV) ribonucleic acid (RNA) for inclusion * Co-morbid systemic illnesses or other severe ...

  10. Remestemcel-l-rknd (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is made from donated human blood. Some human blood products have transmitted certain viruses (eg, HIV, hepatitis B or C) or genetic diseases to ...